Humanin (HN) is a small peptide encoded in mitochondrial DNA, classed as one of the first mitochondrial-derived peptides. It has been studied for proposed cytoprotective and metabolic signalling roles, mostly in preclinical settings.

What does research suggest Humanin does?

Laboratory and animal studies have reported cytoprotective effects, and Humanin is discussed in relation to mitochondrial function, metabolism, and aging. Human evidence is limited and largely observational and mechanistic, so its effects in people are not well established.

Is Humanin an approved medicine?

No. Humanin is not an approved medicine and is considered a research compound. It has not been authorized as a therapeutic by major regulators.

Human safety data for Humanin is limited, and its long-term profile is unknown. Material sold on the research market is unverified in purity and identity, which adds further uncertainty.

What are the side effects of Humanin?

Because human studies are limited, a well-characterized side-effect profile has not been established. The long-term safety profile in humans is currently unknown.

Why is Humanin studied for longevity?

Mitochondrial function declines with age, and Humanin is a mitochondrial-derived peptide with reported cytoprotective and metabolic signalling in preclinical models. This has made it a topic of interest in longevity and metabolic research, though human evidence remains limited.

Why is humanin described as a "mitochondrial-derived peptide"?

Unlike most peptides, whose instructions sit in the cell nucleus, humanin's sequence is encoded within mitochondrial DNA — specifically a stretch of the 16S rRNA gene. That origin is why it is grouped with other mitochondrial-derived peptides and often discussed in the context of mitochondrial signalling and cellular stress responses. This is background biology, not a health claim.

How does humanin differ from the peptides people usually hear about, like GLP-1 drugs or growth-hormone secretagogues?

Those better-known compounds are largely defined by clinical development and, in some cases, regulatory approval for specific uses. Humanin sits at a much earlier stage: it is studied mainly as a piece of basic mitochondrial biology, with limited human data and no approved product. Comparisons framing it as an interchangeable "longevity peptide" overstate how well characterized it is in people.

Is the fact that humanin appears naturally in the body evidence that supplementing it is safe or beneficial?

No. A molecule being naturally present says nothing about the safety or effect of introducing additional material from an unverified research-market source, at unknown purity or amount. Endogenous presence and the behaviour of externally supplied peptide are separate questions, and the human evidence here remains limited and mostly observational.

Where can I buy Humanin and compare vendors?

Use the vendor comparison on this page. It shows only checked, product-specific links and identifies vendor claims, independent documentation and affiliate relationships separately. Availability and legal status can vary by country.

Mitochondrial

Buy Humanin – Vendors, Prices, Testing and Evidence

Buy Humanin

Also known as: HN

Evidence grade C — Early / Preclinical

Short answer

A mitochondrial-derived peptide studied for cytoprotective and metabolic roles. Mostly preclinical.

Where can you buy Humanin?

No peptide-specific vendor offer is currently verified. The vendor catalogue link is provided for discovery only and does not assert availability.

What is known?

Humanin is a peptide encoded in mitochondrial DNA with proposed cytoprotective effects.

What is not established?

Limited; largely observational and mechanistic.

Safety

Human safety data is limited; unverified research-market material.

Regulatory status

Not an approved medicine. Research status.

Not medical advice. This educational reference is not diagnosis, treatment, prescribing, dosing or emergency guidance. Consult a qualified professional before making health-related decisions.

Vendor comparison

Buy Humanin: compare vendors

The table lists only product-specific offers that were checked and for which a real destination exists. Missing prices, quantities, stock and laboratory details are not inferred.

What is it?

Humanin is a peptide encoded in mitochondrial DNA with proposed cytoprotective effects.

Research and evidence

Humanin (HN) is a small peptide notable for where its instructions are stored: unlike most human peptides, it is encoded within mitochondrial DNA rather than the cell nucleus, making it one of the first identified mitochondrial-derived peptides (MDPs). Researchers first isolated Humanin from tissue samples in the context of neurodegeneration studies, and interest has since broadened to its proposed roles in cellular stress responses. In the scientific literature it is most often described as a cytoprotective signalling molecule, meaning it has been studied for how it may help cells resist certain forms of stress and programmed death. peptides.cx catalogs Humanin as an educational reference; it is not an approved medicine and currently sits in research status.

The reasons Humanin is studied cluster around mitochondrial biology, metabolism, and aging. Because mitochondrial function tends to decline with age and is implicated in metabolic conditions, mitochondrial-derived peptides like Humanin are a subject of investigation in longevity and metabolic research, and it frequently appears in discussions of these topics. Reported mechanisms center on cytoprotective and metabolic signalling. It is important to read this evidence honestly: much of what is known about Humanin comes from cell-culture (in vitro) work and animal models, where cytoprotective effects have been reported, rather than from large, controlled human trials.

The human evidence for Humanin is limited and largely observational and mechanistic, so claims that it treats, prevents, or cures any condition are not supported by the current data. Human safety information is likewise limited, and material sold on the research market is unverified in purity and identity; the long-term safety profile in humans is not established. Humanin is not an approved therapeutic and is treated here strictly as a research compound. This page is an evidence-based reference intended to summarize what the science does and does not show — it is not medical advice, and it does not provide dosing, protocols, or sourcing guidance.

Evidence grade: C

Limited; largely observational and mechanistic. Cytoprotective effects reported.

Human evidence

Limited; largely observational and mechanistic.

Animal and preclinical evidence

Cytoprotective effects reported.

Proposed mechanisms

Discussed cytoprotective and metabolic signalling

Safety concerns and known side effects

Human safety data is limited; unverified research-market material.

Unknown long-term profile

Regulatory status

Not an approved medicine. Research status.

Humanin research timeline

2001
Humanin is first described, identified while screening for factors that protect neurons against amyloid-beta toxicity in Alzheimer's-affected brain tissue.
Early 2000s
Researchers map its coding sequence to a region of mitochondrial DNA (the 16S rRNA gene), making it one of the earliest recognized mitochondrial-derived peptides.
2000s
Preclinical studies explore proposed cytoprotective signalling, including interactions with binding partners and candidate cell-surface receptor complexes.
2010s
Work broadens to metabolic and aging-related roles, with observational reports of circulating humanin levels varying with age and in some long-lived populations.
Early 2020s
Interest continues largely within basic and preclinical research; robust human clinical trials remain scarce and no medicine based on humanin is approved.

Frequently asked questions about Humanin

What is Humanin?: Humanin (HN) is a small peptide encoded in mitochondrial DNA, classed as one of the first mitochondrial-derived peptides. It has been studied for proposed cytoprotective and metabolic signalling roles, mostly in preclinical settings.
What does research suggest Humanin does?: Laboratory and animal studies have reported cytoprotective effects, and Humanin is discussed in relation to mitochondrial function, metabolism, and aging. Human evidence is limited and largely observational and mechanistic, so its effects in people are not well established.
Is Humanin an approved medicine?: No. Humanin is not an approved medicine and is considered a research compound. It has not been authorized as a therapeutic by major regulators.
Is Humanin safe?: Human safety data for Humanin is limited, and its long-term profile is unknown. Material sold on the research market is unverified in purity and identity, which adds further uncertainty.
What are the side effects of Humanin?: Because human studies are limited, a well-characterized side-effect profile has not been established. The long-term safety profile in humans is currently unknown.
Why is Humanin studied for longevity?: Mitochondrial function declines with age, and Humanin is a mitochondrial-derived peptide with reported cytoprotective and metabolic signalling in preclinical models. This has made it a topic of interest in longevity and metabolic research, though human evidence remains limited.
Why is humanin described as a "mitochondrial-derived peptide"?: Unlike most peptides, whose instructions sit in the cell nucleus, humanin's sequence is encoded within mitochondrial DNA — specifically a stretch of the 16S rRNA gene. That origin is why it is grouped with other mitochondrial-derived peptides and often discussed in the context of mitochondrial signalling and cellular stress responses. This is background biology, not a health claim.
How does humanin differ from the peptides people usually hear about, like GLP-1 drugs or growth-hormone secretagogues?: Those better-known compounds are largely defined by clinical development and, in some cases, regulatory approval for specific uses. Humanin sits at a much earlier stage: it is studied mainly as a piece of basic mitochondrial biology, with limited human data and no approved product. Comparisons framing it as an interchangeable "longevity peptide" overstate how well characterized it is in people.
Is the fact that humanin appears naturally in the body evidence that supplementing it is safe or beneficial?: No. A molecule being naturally present says nothing about the safety or effect of introducing additional material from an unverified research-market source, at unknown purity or amount. Endogenous presence and the behaviour of externally supplied peptide are separate questions, and the human evidence here remains limited and mostly observational.
Where can I buy Humanin and compare vendors?: Use the vendor comparison on this page. It shows only checked, product-specific links and identifies vendor claims, independent documentation and affiliate relationships separately. Availability and legal status can vary by country.

Common discussion areas

LongevityMitochondria

Sources

Editorial review and transparency

Written by: peptides.cx Editorial Team
Scientific reviewer: No named medical reviewer is currently assigned
Last editorial review: June 1, 2026
Last vendor check: July 18, 2026
Review method: Source review, claim verification, vendor-data separation and regulatory-context review.
Commercial disclosure and conflicts: Vendor relationships do not determine evidence or safety ratings. No named reviewer conflict is recorded because no named reviewer is assigned.

Editorial policy →Evidence grade →Vendor methodology →

Related on peptides.cx

Library →Vendor quality checklist →Safety →Affiliate code: PEPTIDES10